Fonar Total Assets 2006-2019 | FONR
Fonar total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
| Fonar Annual Total Assets (Millions of US $) |
|
|---|---|
| 2019 | $134 |
| 2018 | $118 |
| 2017 | $99 |
| 2016 | $85 |
| 2015 | $76 |
| 2014 | $77 |
| 2013 | $73 |
| 2012 | $34 |
| 2011 | $32 |
| 2010 | $22 |
| 2009 | $28 |
| 2008 | $35 |
| 2007 | $41 |
| 2006 | $57 |
| 2005 | $76 |
| Fonar Quarterly Total Assets (Millions of US $) |
|
|---|---|
| Q4 2019 | $134 |
| Q3 2019 | $127 |
| Q2 2018 | $123 |
| Q1 2018 | $120 |
| Q4 2018 | $118 |
| Q3 2018 | $107 |
| Q2 2017 | $105 |
| Q1 2017 | $101 |
| Q4 2017 | $99 |
| Q3 2017 | $92 |
| Q2 2016 | $88 |
| Q1 2016 | $86 |
| Q4 2016 | $85 |
| Q3 2016 | $82 |
| Q2 2015 | $80 |
| Q1 2015 | $79 |
| Q4 2015 | $76 |
| Q3 2015 | $75 |
| Q2 2014 | $79 |
| Q1 2014 | $79 |
| Q4 2014 | $77 |
| Q3 2014 | $76 |
| Q2 2013 | $77 |
| Q1 2013 | $76 |
| Q4 2013 | $73 |
| Q3 2013 | $73 |
| Q2 2012 | $37 |
| Q1 2012 | $35 |
| Q4 2012 | $34 |
| Q3 2012 | $35 |
| Q2 2011 | $33 |
| Q1 2011 | $33 |
| Q4 2011 | $32 |
| Q3 2011 | $26 |
| Q2 2010 | $24 |
| Q1 2010 | $22 |
| Q4 2010 | $22 |
| Q3 2010 | $23 |
| Q2 2009 | $25 |
| Q1 2009 | $27 |
| Q4 2009 | $28 |
| Q3 2009 | $30 |
| Q2 2008 | $33 |
| Q1 2008 | $33 |
| Q4 2008 | $35 |
| Q3 2008 | $41 |
| Q2 2007 | $41 |
| Q1 2007 | $42 |
| Q4 2007 | $41 |
| Q3 2007 | $48 |
| Q2 2006 | $53 |
| Q1 2006 | $54 |
| Q4 2006 | $57 |
| Q3 2006 | $62 |
| Q2 2005 | $69 |
| Q1 2005 | $70 |
| Q4 2005 | $76 |
| Q3 2005 | $75 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.127B | $0.087B |
| FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $144.122B | 20.23 |
| Abbott Laboratories (ABT) | United States | $141.639B | 26.63 |
| Stryker (SYK) | United States | $79.044B | 27.33 |
| Boston Scientific (BSX) | United States | $52.905B | 25.66 |
| Baxter (BAX) | United States | $44.730B | 27.12 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $31.899B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $27.527B | 17.62 |
| Coloplast (CLPBY) | Denmark | $24.516B | 39.14 |
| Lonza Group Ag (LZAGY) | Switzerland | $24.500B | 0.00 |
| Terumo (TRUMY) | Japan | $23.332B | 26.83 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $20.451B | 0.00 |
| ResMed (RMD) | United States | $18.758B | 35.74 |
| Sunny Optical Technology (SNPTF) | China | $16.343B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.664B | 51.80 |
| Insulet (PODD) | United States | $9.336B | 553.21 |
| Canopy Growth (CGC) | Canada | $7.103B | 0.00 |
| Perrigo (PRGO) | Ireland | $7.075B | 13.03 |
| Hill-Rom Holdings (HRC) | United States | $6.550B | 19.53 |
| Haemonetics (HAE) | United States | $6.367B | 48.05 |
| William Demant Holdings (WILYY) | Denmark | $5.988B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $5.322B | 27.49 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $4.296B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $3.796B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.645B | 0.00 |
| Neogen (NEOG) | United States | $3.284B | 54.96 |
| NuVasive (NUVA) | United States | $3.263B | 26.01 |
| ICU Medical (ICUI) | United States | $3.151B | 20.44 |
| Quidel (QDEL) | United States | $2.356B | 23.39 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $2.303B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.869B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.827B | 39.44 |
| Cardiovascular Systems (CSII) | United States | $1.586B | 0.00 |
| Aphria (APHA) | $1.164B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.064B | 24.53 |
| AtriCure (ATRC) | United States | $0.978B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.849B | 13.81 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.823B | 20.97 |
| Omeros (OMER) | United States | $0.745B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.737B | 0.00 |
| PetIQ (PETQ) | United States | $0.722B | 17.07 |
| Lantheus Holdings (LNTH) | United States | $0.721B | 18.96 |
| Cerus (CERS) | United States | $0.623B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.622B | 36.89 |
| Surmodics (SRDX) | United States | $0.569B | 108.08 |
| MacroGenics (MGNX) | United States | $0.553B | 0.00 |
| Quanterix (QTRX) | United States | $0.529B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.491B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.461B | 21.34 |
| Owens & Minor (OMI) | United States | $0.410B | 12.28 |
| Meridian Bioscience (VIVO) | United States | $0.377B | 11.76 |
| Zynex (ZYXI) | United States | $0.362B | 38.41 |
| Utah Medical Products (UTMD) | United States | $0.349B | 25.56 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.312B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.304B | 93.44 |
| United Health Products (UEEC) | United States | $0.242B | 0.00 |
| Bovie Medical (APYX) | United States | $0.223B | 0.00 |
| Vapotherm (VAPO) | United States | $0.167B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.156B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.137B | 0.00 |
| Female Health (VERU) | United States | $0.134B | 0.00 |
| Chimerix (CMRX) | United States | $0.100B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.097B | 0.00 |
| United-Guardian (UG) | United States | $0.084B | 19.84 |
| Nephros (NEPH) | United States | $0.068B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.061B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.055B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| Surface Oncology (SURF) | United States | $0.033B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.023B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.021B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.011B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.009B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.007B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.005B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.003B | 0.00 |
